ERBB3, CD69, PTPN22, and IL27 have a highly significant correlation with T1DM.
← all excerpts
Based on systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for diabetes.
1
—
—
ERBB3, CD69, PTPN22, and IL27 have a highly significant correlation with T1DM.